Literature DB >> 25304685

DAPK3 suppresses acini morphogenesis and is required for mouse development.

Brandon A Kocher1, Lynn S White1, David Piwnica-Worms2.   

Abstract

UNLABELLED: Death-associated protein kinase (DAPK3) is a serine/threonine kinase involved in various signaling pathways important to tissue homeostasis and mammalian biology. Considered to be a putative tumor suppressor, the molecular mechanism by which DAPK3 exerts its suppressive function is not fully understood and the field lacks an appropriate mouse model. To address these gaps, an in vitro three-dimensional tumorigenesis model was used and a constitutive DAPK3-knockout mouse was generated. In the 3D morphogenesis model, loss of DAPK3 through lentiviral-mediated knockdown enlarged acinar size by accelerated acini proliferation and apoptosis while maintaining acini polarity. Depletion of DAPK3 enhanced growth factor-dependent mTOR activation and, furthermore, enlarged DAPK3 acini structures were uniquely sensitive to low doses of rapamycin. Simultaneous knockdown of RAPTOR, a key mTORC1 component, reversed the augmented acinar size in DAPK3-depleted structures indicating an epistatic interaction. Using a validated gene trap strategy to generate a constitutive DAPK3-knockout mouse, it was demonstrated that DAPK3 is vital for early mouse development. The Dapk3 promoter exhibits spatiotemporal activity in developing mice and is actively expressed in normal breast epithelia of adult mice. Importantly, reduction of DAPK3 expression correlates with the development of ductal carcinoma in situ (DCIS) and more aggressive breast cancer as observed in the Oncomine database of clinical breast cancer specimens. IMPLICATIONS: Novel cellular and mouse modeling studies of DAPK3 shed light on its tumor-suppressive mechanisms and provide direct evidence that DAPK3 has relevance in early development. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25304685      PMCID: PMC4336824          DOI: 10.1158/1541-7786.MCR-14-0333

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  35 in total

1.  Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization.

Authors:  Johanna I Partanen; Anni I Nieminen; Tomi P Mäkelä; Juha Klefstrom
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-31       Impact factor: 11.205

2.  Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.

Authors:  D D Sarbassov; David A Guertin; Siraj M Ali; David M Sabatini
Journal:  Science       Date:  2005-02-18       Impact factor: 47.728

Review 3.  ZIP kinase, a key regulator of myosin protein phosphatase 1.

Authors:  Timothy A J Haystead
Journal:  Cell Signal       Date:  2005-11       Impact factor: 4.315

Review 4.  The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer.

Authors:  Britta Weigelt; Cyrus M Ghajar; Mina J Bissell
Journal:  Adv Drug Deliv Rev       Date:  2014-01-09       Impact factor: 15.470

5.  Physical and functional interactions between STAT3 and ZIP kinase.

Authors:  Noriko Sato; Taro Kawai; Kenji Sugiyama; Ryuta Muromoto; Seiyu Imoto; Yuichi Sekine; Masato Ishida; Shizuo Akira; Tadashi Matsuda
Journal:  Int Immunol       Date:  2005-10-11       Impact factor: 4.823

6.  A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen.

Authors:  Jason Moffat; Dorre A Grueneberg; Xiaoping Yang; So Young Kim; Angela M Kloepfer; Gregory Hinkle; Bruno Piqani; Thomas M Eisenhaure; Biao Luo; Jennifer K Grenier; Anne E Carpenter; Shi Yin Foo; Sheila A Stewart; Brent R Stockwell; Nir Hacohen; William C Hahn; Eric S Lander; David M Sabatini; David E Root
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

7.  Zipper-interacting protein kinase is involved in regulation of ubiquitination of the androgen receptor, thereby contributing to dynamic transcription complex assembly.

Authors:  A Felten; D Brinckmann; G Landsberg; K H Scheidtmann
Journal:  Oncogene       Date:  2012-11-12       Impact factor: 9.867

8.  The NF1 tumor suppressor critically regulates TSC2 and mTOR.

Authors:  Cory M Johannessen; Elizabeth E Reczek; Marianne F James; Hilde Brems; Eric Legius; Karen Cichowski
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-03       Impact factor: 11.205

9.  Death-associated protein kinase phosphorylates mammalian ribosomal protein S6 and reduces protein synthesis.

Authors:  Andrew M Schumacher; Anastasia V Velentza; D Martin Watterson; John Dresios
Journal:  Biochemistry       Date:  2006-11-14       Impact factor: 3.162

10.  RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation.

Authors:  Philippe P Roux; David Shahbazian; Hieu Vu; Marina K Holz; Michael S Cohen; Jack Taunton; Nahum Sonenberg; John Blenis
Journal:  J Biol Chem       Date:  2007-03-14       Impact factor: 5.157

View more
  3 in total

1.  ZIPK mediates endothelial cell contraction through myosin light chain phosphorylation and is required for ischemic-reperfusion injury.

Authors:  Yiteng Zhang; Chenghai Zhang; He Zhang; Weiwei Zeng; Shuai Li; Caiping Chen; Xiaobin Song; Jie Sun; Zhiyuan Sun; Congcong Cui; Xiang Cao; Lirong Zheng; Pei Wang; Wei Zhao; Zhao Zhang; Yun Xu; Minsheng Zhu; Huaqun Chen
Journal:  FASEB J       Date:  2019-06-10       Impact factor: 5.191

Review 2.  Orange is the new black: Kinases are the new master regulators of tumor suppression.

Authors:  Elvira An; John Brognard
Journal:  IUBMB Life       Date:  2018-12-11       Impact factor: 3.885

3.  The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the STING-IFN-β pathway.

Authors:  Mariko Takahashi; Chan-Wang J Lio; Anaamika Campeau; Martin Steger; Ferhat Ay; Matthias Mann; David J Gonzalez; Mohit Jain; Sonia Sharma
Journal:  Nat Immunol       Date:  2021-03-25       Impact factor: 25.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.